Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
Quick Stats
Jun 03, 202651.7
AI Score
HOLD0.76
Volume Ratio
Aug 03, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
SNDX Stock Summary
Last updated Jun 03, 2026
SNDX is currently trading at $18.34, positioned below its 200-day moving average of $19.38, suggesting bearish momentum. The stock has a 52-week range of $8.585 to $25.59.
Technical Analysis: The 50-day moving average stands at $21.78, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 32.637, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.235, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SNDX at 51.7/100 with a HOLD recommendation.
SNDX (Syndax Pharmaceuticals, Inc.) Indicators
Last updated Jun 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 32.637 |
| CMF (20) | -0.235 |
| ROC (10) | -5.493 |
| ADX (14) | 19.484 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.784 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -93.742 |
| MFI (14) | 31.982 |
SNDX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SNDX Price vs Max Options Open Interest
SNDX Max Change In Options Open Interest
SNDX Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SNDX Daily Out of Money Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SNDX Daily In the Money Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SNDX Most Active Options by Volume(near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Syndax Pharmaceuticals, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
SNDX Moving Averages Analysis
SNDX (Syndax Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated Jun 03, 2026
| Days | MA |
|---|---|
| 10 | 19.43 |
| 20 | 19.96 |
| 30 | 20.23 |
| 50 | 21.78 |
| 100 | 21.67 |
| 200 | 19.38 |
SNDX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.6 billion |
| Earnings/Share ($) | -2.79 |
| Net Proft Margin (%) | -1.1201 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.6856 |
| EPS Estimate Next Year ($) | -0.4706 |
| WallStreet Target Price ($) | 39.25 |
| Most Recent Quarter |